Immunitybio Inc (NASDAQ:IBRX)

3.99
Delayed Data
As of Jul 01
 +0.27 / +7.26%
Today’s Change
2.60
Today|||52-Week Range
14.59
-34.37%
Year-to-Date
No recent news for Immunitybio Inc.

Today’s Trading

Previous close3.72
Today’s open3.70
Day’s range3.70 - 4.06
Volume60,100
Average volume (3 months)1,800,388
Market cap$1.6B
Data as of 3:59pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)+0.13%
Earnings growth (this year)-1.12%
Earnings growth (next 5 years)-47.93%
Revenue growth (last year)+741.44%
P/E ratioNM
Price/Sales2,533.77
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TVTXTravere Therapeutics...+0.85+3.51%
AXSMAxsome Therapeutics ...+2.35+6.14%
EBSEmergent BioSolution...+0.75+2.42%
AUPHAurinia Pharmaceutic...+1.33+13.23%
Data as of 5:39pm ET, 07/01/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$934.0K
Annual profit (last year)-$346.8M
Net profit margin-37,129.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts